Amerinet Adds MultiHance to Offering of Bracco Products

Bracco Diagnostics, which develops and manufactures a number of radiology, radiopharmaceutical and other diagnostic imaging products, and Amerinet, one of the leading health care group purchasing organizations in the U.S., have announced the inclusion of MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, into the companies' previously established product purchasing agreement.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050127005567&newsLang=en)